The proton pump inhibitor rabeprazole had a small, but significant effect in reducing laryngopharyngeal reflux symptoms after 12 weeks of treatment, Dr. Paul K.Y. Lam and colleagues reported in an article appearing in the September issue of Clinical Gastroenterology and Hepatology. The results are in contrast to those of previous, smaller studies that did not find PPIs to be of benefit in laryngopharyngeal reflux (LPR), wrote the authors.
